<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00624871</url>
  </required_header>
  <id_info>
    <org_study_id>2004-MD-thesis-ahmed</org_study_id>
    <nct_id>NCT00624871</nct_id>
  </id_info>
  <brief_title>Ascorbic Acid and Ibuprofen in Infants With Hypoxic Ischemic Encephalopathy</brief_title>
  <official_title>Ascorbic Acid Combined With Ibuprofen in Hypoxic Ischemic Encephalopathy: A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Al-Azhar University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Al-Azhar University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Oxygen radicals and inflammation are important causes for brain injury in neonates following
      perinatal asphyxia. Animal studies demonstrated potential benefits to the brain when using
      both of vitamin C and ibuprofen. The efficacy of these 2 drugs when combined in protecting
      the human brain has not been studied. We aimed in this study to test the hypothesis that a
      combination of anti-oxidants (vitamin C) and anti-inflammatory (ibuprofen) drugs can decrease
      the brain injury in perinatal asphyxia and improve outcomes when given to infants immediately
      after birth.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2004</start_date>
  <completion_date type="Actual">April 2006</completion_date>
  <primary_completion_date type="Actual">April 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>DDST-II</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurological Examination</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>On Discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological Examination</measure>
    <time_frame>On Discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Hypoxic Ischemic Encephalopathy</condition>
  <condition>Perinatal Asphyxia</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infants will receive intravenous ascorbic acid and oral ibuprofen for 3 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Infants will receive equivalent amount of placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ascorbic acid (vitamin C)</intervention_name>
    <description>IV, 100 mg/kg/day, every day, for 3 days</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>PO, 10 mg/kg on day 1, 5 mg/kg/day on days 2 and 3 of life</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Apgar score at 5 minutes &lt; 6

          -  Profound metabolic or mixed acidosis with pH &lt; 7 in the initial blood gas

          -  Evidence of encephalopathy such as coma, seizures or hypotonia

          -  Evidence of multi-system compromise, in addition to encephalopathy

        Exclusion Criteria:

          -  Major congenital anomalies

          -  Early sepsis

          -  Gastrointestinal bleeding

          -  Thrombocytopenia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Elsayed, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Al-Azhar University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laila Abd-Rabboh, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Al-Azhar University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bab El-Shariya Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2008</study_first_submitted>
  <study_first_submitted_qc>February 27, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 28, 2008</study_first_posted>
  <last_update_submitted>February 27, 2008</last_update_submitted>
  <last_update_submitted_qc>February 27, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 28, 2008</last_update_posted>
  <responsible_party>
    <name_title>Ahmed Helal Elsayed</name_title>
    <organization>Al-Azhar University</organization>
  </responsible_party>
  <keyword>Interleukin 1-beta</keyword>
  <keyword>Interleukin 6</keyword>
  <keyword>Vitamin C</keyword>
  <keyword>HIE</keyword>
  <keyword>neonates</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Hypoxia-Ischemia, Brain</mesh_term>
    <mesh_term>Asphyxia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

